surf break copy_edited.jpg
surbreak-19.png
Search

Report: In big shift, medtech executives grow fonder of U.S. regulatory process

By: Joel Berg


Executives used to lean toward European regulators launching their products in that region. But after a decade of change, they now see the U.S. as a better option. While the FDA gets kudos, the other issue remains challenging: reimbursement.


CONTINUE READING

Recent Posts

See All

Spring has sprung across the U.S., and many of you are probably ready to hit the course and outdoor courts. But a recent injury may be interrupting your golf game or tennis match. If you’re hesitant o

WM360_logo-18.png